California Public Employees Retirement System’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-145,900
| Closed | -$4.44M | – | 2410 |
|
|
2021
Q1 | $4.44M | Sell |
145,900
-13,446
| -8% | -$382K | ﹤0.01% | 1506 |
|
|
2020
Q4 | $3.15M | Sell |
159,346
-3,000
| -2% | -$48.4K | ﹤0.01% | 1706 |
|
|
2020
Q3 | $2.12M | Buy |
162,346
+4,800
| +3% | +$60.7K | ﹤0.01% | 1800 |
|
|
2020
Q2 | $1.79M | Sell |
157,546
-900
| -0.6% | -$12.8K | ﹤0.01% | 1858 |
|
|
2020
Q1 | $2.27M | Sell |
158,446
-22,700
| -13% | -$480K | ﹤0.01% | 1533 |
|
|
2019
Q4 | $4.93M | Buy |
181,146
+10,561
| +6% | +$291K | ﹤0.01% | 1467 |
|
|
2019
Q3 | $4.88M | Buy |
170,585
+27,970
| +20% | +$815K | ﹤0.01% | 1322 |
|
|
2019
Q2 | $3.96M | Sell |
142,615
-18,767
| -12% | -$530K | ﹤0.01% | 1262 |
|
|
2019
Q1 | $5.36M | Sell |
161,382
-3,302
| -2% | -$101K | 0.01% | 1126 |
|
|
2018
Q4 | $4.79M | Sell |
164,684
-16,074
| -9% | -$578K | 0.01% | 1147 |
|
|
2018
Q3 | $8.32M | Buy |
180,758
+14,205
| +9% | +$632K | 0.01% | 987 |
|
|
2018
Q2 | $6.22M | Sell |
166,553
-105,372
| -39% | -$3.56M | 0.01% | 1175 |
|
|
2018
Q1 | $8.04M | Sell |
271,925
-46,692
| -15% | -$1.58M | 0.01% | 1016 |
|
|
2017
Q4 | $10.9M | Buy |
318,617
+33,337
| +12% | +$1.12M | 0.01% | 869 |
|
|
2017
Q3 | $10.3M | Buy |
285,280
+10,280
| +4% | +$293K | 0.02% | 853 |
|
|
2017
Q2 | $7.11M | Buy |
275,000
+17,100
| +7% | +$363K | 0.01% | 1034 |
|
|
2017
Q1 | $4.95M | Buy |
257,900
+18,400
| +8% | +$326K | 0.01% | 1281 |
|
|
2016
Q4 | $3.99M | Sell |
239,500
-25,700
| -10% | -$465K | 0.01% | 1438 |
|
|
2016
Q3 | $5.46M | Sell |
265,200
-17,200
| -6% | -$436K | 0.01% | 1234 |
|
|
2016
Q2 | $8.64M | Sell |
282,400
-8,400
| -3% | -$292K | 0.01% | 913 |
|
|
2016
Q1 | $10.9M | Sell |
290,800
-16,800
| -5% | -$633K | 0.02% | 797 |
|
|
2015
Q4 | $13.3M | Buy |
307,600
+13,400
| +5% | +$566K | 0.02% | 711 |
|
|
2015
Q3 | $11M | Hold |
294,200
| – | – | 0.02% | 794 |
|
|
2015
Q2 | $10M | Sell |
294,200
-10,400
| -3% | -$354K | 0.02% | 911 |
|
|
2015
Q1 | $11.5M | Hold |
304,600
| – | – | 0.02% | 864 |
|
|
2014
Q4 | $11.5M | Buy |
304,600
+10,400
| +4% | +$369K | 0.02% | 864 |
|
|
2014
Q3 | $11.3M | Sell |
294,200
-230,230
| -44% | -$8.59M | 0.02% | 882 |
|
|
2014
Q2 | $20.4M | Sell |
524,430
-67,210
| -11% | -$2.5M | 0.03% | 627 |
|
|
2014
Q1 | $23.9M | Buy |
591,640
+26,240
| +5% | +$813K | 0.03% | 540 |
|
|
2013
Q4 | $13.7M | Buy |
565,400
+312,448
| +124% | +$7.9M | 0.02% | 779 |
|
|
2013
Q3 | $5.94M | Buy |
252,952
+31,400
| +14% | +$892K | 0.01% | 1130 |
|
|
2013
Q2 | $5.95M | Buy |
+221,552
| New | +$6.42M | 0.01% | 1020 |
|
Other funds holding MYGN
PHS
CCM
California Public Employees Retirement System's MYGN Position: Q2 2021 in Review
California Public Employees Retirement System sold out of Myriad Genetics (MYGN) in Q2 2021, closing a stake of 145,900 shares — an estimated $4.44M sold.
California Public Employees Retirement System first reported a position in MYGN in Q2 2013 and held it in 32 quarters. The position peaked at $23.9M in Q1 2014. 201 funds tracked by Wall St. Rank hold MYGN as of Q2 2021.
- California Public Employees Retirement System reported no remaining Myriad Genetics position as of Q2 2021 after selling out during the quarter.
- California Public Employees Retirement System sold 145,900 Myriad Genetics shares in Q2 2021, an estimated $4.44M.
- California Public Employees Retirement System first reported a position in Myriad Genetics in Q2 2013 and held it in 32 quarters.
- California Public Employees Retirement System's Myriad Genetics position peaked at $23.9M in Q1 2014.
- 201 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2021.
Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.